• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2004

View Archived Issues

Effective cytolysis of Hodgkin's lymphoma tumor cells by antibody-cytokine fusion protein

Read More

Phase II study of GDNF for Parkinson's fails to meet primary endpoint

Read More

Priority review and accelerated approval designations for Antegren BLA

Read More

Aplidin receives orphan drug status for ALL

Read More

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

Read More

FDA accepts IND for MN-029

Read More

Fast track status for INO-1001 for patients with STEMI

Read More

IND accepted for phase II trials of ORG-25969

Read More

Favorable results for ACP-103 for use in Parkinson's patients

Read More

Exelixis submits IND for XL-999

Read More

Europe's CHMP hands down positive opinion for MabThera in indolent NHL

Read More

Bionomics progress in gene test for epilepsy

Read More

Retinoic metabolism inhibitors promising against prostate cancer

Read More

Novel SERM with minimal ovarian effects

Read More

New melatonin receptor ligands prepared and tested by French scientists

Read More

Novel modulators of nAChR and monoamine receptors or transporters claimed by NeuroSearch

Read More

Servier researchers describe novel cognition-enhancing agents

Read More

New IGF-1R inhibitors with potential in cancer therapy

Read More

Novel topoisomerase inhibitors identified by researchers at State U. of New Jersey

Read More

Novel fusion-targeting antiviral agents presented by Trimeris

Read More

New MCH receptor modulators in early development at Tularik

Read More

Femara sNDA granted priority review by FDA

Read More

Erbitux receives E.U. approval for metastatic colorectal cancer

Read More

FDA clears IND for study of VPI-013 in patients with major depressive disorder

Read More

IND submission to start phase I trial of thrombin inhibitor ARC-183

Read More

Enrollment open in phase III trial of Veronate

Read More

Tularik stockholders to meet in August to vote on acquisition by Amgen

Read More

Arava approved in Europe for active psoriatic arthritis

Read More

Vasopressin V2 receptor antagonist effective aquaretic in vivo

Read More

PXD-101 enters phase I trial in hematologic cancer

Read More

Exenatide NDA submission for type 2 diabetes

Read More

Selective glucocorticoid receptor modulator may prevent progression of multiple sclerosis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe